← Eichor
Study identifier: NCT06222606 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Surgery for Thyroid Cancer With or Without Autofluorescence to Prevent Hypoparathyroidism

Condition: Thyroid Cancer  ·  Sponsor: Aarhus University Hospital

PhaseNA
Planned participants160
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The study aims to test if use of autofluorescence imaging (AF) reduces the risk of developing hypoparathyroidism (hypoPT) following surgery for thyroid cancer, either total thyroidectomy (TT) or completion hemithyroidectomy (cHT).

This description comes directly from the study's public registry record.

Talk to the study team

Jacob Kinggaard Lilja-Fischer, MD  ·  +4540460399  ·  jaclil@rm.dk

Lars Rolighed, MD, PhD  ·  larsroli@rm.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Aarhus University HospitalAarhus, Denmark, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06222606